Haemophagocytic Lymphohistiocytosis Triggered by Cytomegalovirus Reactivation in An Immunosuppressed Patient with Pauci-Immune Glomerulonephritis

免疫抑制少免疫性肾小球肾炎患者巨细胞病毒再激活诱发噬血细胞性淋巴组织细胞增生症

阅读:3

Abstract

We report on a 67-year-old male patient admitted to the Internal Medicine department for fever, joint pain and exertional dyspnoea. Two months before his admission, the patient had been diagnosed with pauci-immune necrotising glomerulonephritis, for which he had been treated with rituximab and corticosteroids. Upon admission the patient was stable, but within a few hours he became unstable as liver failure and acute cytopaenia occurred. Blood investigations revealed cytopaenia, altered coagulation tests, high ferritin, triglycerides, lactate dehydrogenase and C-reactive protein levels, and severe cytocholestasis. A liver echography was normal. The patient had been transferred to the intensive care unit to receive supportive support when the cytomegalovirus polymerase chain reaction (CMV-PCR) test came back positive. The diagnosis of haemophagocytic lymphohistiocytosis associated with a CMV infection and/or reactivation in an immunosuppressed patient was made. Specific treatment was administrated, along with symptomatic treatment. The patient clinically improved during hospitalisation with complete resolution of symptoms. LEARNING POINTS: Haemophagocytic lymphohistiocytosis (HLH) is a rare disease yet important to diagnose, as it is quickly life-threatening.The diverse symptoms of HLH can make diagnosis tricky, with many potential causes. As clinical presentation is not very specific, it is often mistaken for infection with severe sepsis and its diagnosis is often delayed.Limited understanding of this condition could lead to worse outcomes for patients. Recognising it early is crucial for starting the right treatment and enhancing both the well-being and survival chances of those affected by this complex disorder.In practice, HLH must be suspected when bi/pancytopaenia occurs in a patient presenting a high fever of unknown cause, especially when they have a history of immunosuppression. Managing it often requires a range of approaches, such as intensive care, immune system suppression, specialised medications or even stem cell transplants.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。